Endothelin-1-mediated inflammation in acute renal failure

Critical Care Nursing Quarterly

Volumn 29, Issue 2, 2006, Pages 152-156

  Angerio, Allan D ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Bosentan; Endothelin 1; ET B receptor; ETA receptor

Indexed keywords

CATECHOLAMINE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE AGENT; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR; TAK 044;

ACUTE KIDNEY FAILURE; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CIRCULATION; KIDNEY TUBULE NECROSIS; NONHUMAN; REVIEW; UPREGULATION; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG SCREENING; IMMUNOLOGY; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOTHELIN-1; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INTERLEUKIN-1; KIDNEY FAILURE, ACUTE; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTION;

EID: 33745010011     PISSN: 08879303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002727-200604000-00009     Document Type: Review

References (46)

1. Liano F, Pascual J, Gamez C, et al. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int. 1996;50:811-818.
2. Chertow GM, Levy EM, Hammermeister KE, et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343-348.
3. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;1115-1122.
4. Peco-Antic A, Nastic-Miric D, Popovic-Rolovic M, et al. Endothelin-1 in acute renal failure. Ren Fail. 1996;18:553-556.
5. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
6. Firth JD, Rateliffe PJ, Raine AEG, et al. Endothelin: an important factor in acute renal failure? Lancet. 1988;ii:1179-1181.
7. Kon V, Badr KF. Biological actions and pathophysiological significance of endothelin in the kidney. Kidney Int. 1991;40:1-12.
8. Nambi P, Pullen M, Wu HL, et al. Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology. 1992;131:1081-1086.
9. Nambi P, Wu HL, Pullen M, et al. Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Mol Pharmacol. 1992;42:336-339.
10. B receptor, is protective against ischemic renal failure in rats. Jpn J Pharmacol. 2000;82:307-316.
11. Pittner J, Wolgast M, Casellas D, et al. Increased shear stress-released NO and decreased endothelial calcium in rat isolated perfused juxtamedullary nephrons. Kidney Int. 2005;67:227-236.
12. Kohzuki M, Johnston CI, Chai SY, et al. Localization of endothelin receptors in the rat kidney. Eur J Pharmacol. 1989;160:193-194.
13. Wilhelm SM, Simonson MS, Robinson AV, et al. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int. 1999;55:1011-1018.
14. Nord EP. Renal actions of endothelin. Kidney Int. 1989;160:193-194.
15. Masaki T, Vane JR, Vanhoutte PM. International union of pharmacology nomenclature of endothelin receptors. Pharmacol Rev. 1994;46:137-142.
16. 2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury. Eur J Pharmacol. 2003;478:187-198.
17. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Eng J Med. 1999;341:577-585.
18. Newaz MA, Oyekan AO. Vascular responses to endothelin-1, angiotensin-II, and U46619 in glycerol-induced acute renal failure. J Cardiovasc Pharmacol. 2001;38:569-577.
19. 2, and catecholamines in the renal constrictor response to angiotensin II. Kidney Int. 2005;67(suppl 93):S3-S9.
20. Endelstein CL, Ling H, Schrier RW. The nature of renal cell injury. Kidney Int. 1997;51:1341-1351.
21. Bellomo R, May C,Wan L. Acute renal failure and sepsis. N Eng J Med. 2004;351:2347.
22. Schrier RW, Wang W. Acute renal failure and sepsis. N Eng J Med. 2004;351:159-169.
23. Angerio AD, Bufalino D, Bresnick M, et al. Inflammatory bowel disease and endothelin-1. Crit Care Nurs Q. 2005;28(2):208-213.
24. Scimone ML, Lutzky VP, Zitterman SI, et al. Migration of polymorphonuclear leucocytes is influenced by dendritic cells. Immunology. 2005;114:375-385.
25. Coppo R, Amore A. New perspectives in treatment of glomerulonephritis. Pediatr Nephrol. 2004;19:256-265.
26. Gould SE, Day M, Jones SS, et al. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 2002;61:51-60.
27. Ross R. The pathogenesis of atherosclerosis. Nature. 1993;362:801-809.
28. Bacon CR, Cary NRB, Davenport AP. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res. 1996;79:794-801.
29. Kirchengast M, MÜnter K. Endothelin-1 and endothelin receptor antagonists in cardiovascular remodeling. PSEBM. 1999;221:312-325.
30. Angerio AD, Fink DA. New strategies in the prevention of restenosis. Crit Care Nurs Q. 2001;24(1):62-68.
31. Ishizuka T, Takamizawa-Matsumoto M, Suzuki K, et al. Endodthelin-1 enhances vascular cell adhesion molecule-1 expression in tumor necrosis factor α-stimulated vascular endothelial cells. Eur J Pharmacol. 1999;369:237-245.
32. Molet S, Furukawa K, Maghazecki A, et al. Chemokine- and cytokine- induced expression of endothelin 1 and endothelin - converting enzyme 1 in endothelial cells. J Allergy Clin Immunol. 2000;105:333-338.
33. Milo O, Cotter G, Kaluski E, et al. Comparison of inflammatory and neuro-bormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol. 2003;92:222-226.
34. Bucher M, Taeger K. Endothelin-receptor gene-expression in rat endotoxemia. Intensive Care Med. 2002;28:642-647.
35. Cao CC, Ding XQ, Ou ZL, et al. In vivo transfection of NF-KB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int. 2004;65:834-835.
36. Brooks DP, DePalma PD, Gellai M, et al. Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ 123 on acute renal failure in anesthetized dogs. J Phamacol Exp Ther. 1994;271:1-7.
37. Gellai M, Jugur M, Fletcher T, et al. Reversal of postischemic acute renal failure with a selective endothelin a receptor antagonist in the rat. J Clin Invest. 1994;93:900-906.
38. A) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation. Transplant Int. 1996;9:201-207.
39. Mitaka C, Hirata Y, Yokoyama K, et al. Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist. Crit Care Med. 1999;27:146-153.
40. Benigni A, Remuzzi G. Endothelin antagonists. Lancet. 1999;353:133-138.
41. Ruschitzka F, Shaw S, Gygi D, et al. Endothelin dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol. 1999;10:953-962.
42. Bohm F, Beltran E, Pernow J. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition. J Int Med. 2005;257:263-271.
43. Kirchengart M, Matthias L. Endothelin receptor antagonists. Clinical realities and future directions. J Cardiovasc Pharmacol. 2005;45:182-191.
44. Kieran NE, Doran PP, Connolly SB, et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 2003;64:480-492.
45. Tong W, Hurley S, Hayashi PH. Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast! Postgrad Med. 2004;116(6):15-24.
46. Bohm F, Settergren M, Gonon AT, et al. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Clin Sci. 2005;108:357-363.